The capital story starts with the antenna. On January 16, 2024, AST & Science was granted %s, “Low earth orbit mechanical deployable structure,” classified in B64G 1/222 with antenna ties in H01Q 1/02. The inventor list runs through AST's senior engineering leadership. AST SpaceMobile trades publicly (ASTS), and its filings put the cash and dilution context behind this hardware on the record.
AST's bet is direct-to-cell: connecting ordinary smartphones directly to satellites, with no special terminal. The physics of doing that require an enormous antenna aperture in orbit — far larger than a conventional satellite. The only way to fly something that big is to launch it folded and deploy it in orbit, which is exactly what this mechanical deployable-structure patent covers. The capability and the capex are inseparable: the bigger the array, the bigger the bet.
For a capital-markets reader, that is the heart of the ASTS story. The deployable-structure IP is the technical engine of the thesis, but the same scale that makes direct-to-cell possible is what drives the capital intensity — large, complex satellites are expensive to build and launch, and the company must fund a meaningful fleet before service revenue scales. The patent describes the asset; the filings describe the runway needed to pay for it.
The disciplined caveat: a deployable-structure patent proves the mechanism, not the constellation's funding or its revenue. The gap between a deployed test array and a funded operational fleet is where the capital risk lives, and that is a balance-sheet question, not a patent one.
But the linkage is the read. AST's antenna is its product, its moat, and its capex all at once — and a deployable-structure patent is the clearest engineering statement of why the capital story is as large as it is.